Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Co-Diagnostics Inc. (CODX)

14.82   0.51 (3.56%) 09-20 01:24
Open: 14.15 Pre. Close: 14.31
High: 14.99 Low: 14.07
Volume: 2,389,119 Market Cap: 438M
Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. The company is headquartered in Salt Lake City, Utah and currently employs 21 full-time employees. The firm is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. The company also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The firm uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.997 - 15.071 15.071 - 15.146
Low: 13.903 - 13.977 13.977 - 14.051
Close: 14.459 - 14.578 14.578 - 14.699

Technical analysis

as of: 2020-09-18 4:29:28 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 20.62     One year: 27.54
Support: Support1: 8.07    Support2: 6.71
Resistance: Resistance1: 17.66    Resistance2: 23.58
Pivot: 11.46
Moving Average: MA(5): 13.03     MA(20): 12.06
MA(100): 17.26     MA(250): 9.37
MACD: MACD(12,26): -1.44     Signal(9): -2.11
Stochastic oscillator: %K(14,3): 79.50     %D(3): 73.83
RSI: RSI(14): 51.74
52-week: High: 30.99  Low: 0.85  Change(%): 1201.8
Average Vol(K): 3-Month: 436243  10-Days: 728760

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CODX has closed below upper band by 2.7%. Bollinger Bands are 19.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 18 Sep 2020
Here is why Co-Diagnostics Inc. (CODX) stock volatility recorded over the last month was 14.12% - The InvestChronicle

Fri, 18 Sep 2020
The Forecast Just Changed on Co-Diagnostics Inc. (NASDAQ:CODX) - The Oracle Dispatch

Fri, 18 Sep 2020
Is Co-Diagnostics Stock a Buy? - Nasdaq

Thu, 17 Sep 2020
Is a Correction Looming Ahead for Co-Diagnostics, Inc. (CODX) - The News Heater

Wed, 16 Sep 2020
Should Co-Diagnostics Inc (CODX) Stock Be in Your Portfolio? - InvestorsObserver

Fri, 11 Sep 2020
Co-Diagnostics, Inc. Announces Details to Access Presentation at H.C. Wainwright Global Investment Conference - Yahoo Finance

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Outperform Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 28
Shares Float (M) 26
% Held by Insiders 24.21
% Held by Institutions 9.17
Shares Short (K) 7,850
Shares Short P. Month (K) 6,220

Stock Financials

EPS 0.350
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.190
Profit Margin 31.42
Operating Margin 31.02
Return on Assets (ttm) 23.9
Return on Equity (ttm) 42.4
Qtrly Rev. Growth 38942.9
Gross Profit (p.s.) 0.004
Sales Per Share 0.917
EBITDA (p.s.) 0.287
Qtrly Earnings Growth
Operating Cash Flow (M) -3
Levered Free Cash Flow (M) -6

Stock Valuations

PE Ratio 41.66
PEG Ratio
Price to Book value 12.25
Price to Sales 15.90
Price to Cash Flow -128.74

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.